Sam Milliken
Overview
Explore the profile of Sam Milliken including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
440
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chadwick V, Kim M, Mills G, Tang C, Anazodo A, Dear R, et al.
Intern Med J
. 2023 Nov;
54(5):750-754.
PMID: 37929784
Background: Chemotherapy is potentially harmful to a developing foetus, and there are limited data on the foetal impact of chemoimmunotherapy (CIT). Therefore, determining pregnancy status prior to initiation of CIT...
2.
Mills G, Chadwick V, Tang C, Perram J, Anderson M, Anazodo A, et al.
Lancet Haematol
. 2023 Jun;
10(6):e458-e467.
PMID: 37263722
The management of potentially life-threatening malignancies in pregnancy is complicated by a lack of robust safety and efficacy evidence. This data shortage stems from a historical exclusion of women of...
3.
Blennerhassett R, Othman J, Biscoe A, Kliman D, Mills G, Blyth E, et al.
Intern Med J
. 2023 Mar;
53(11):1979-1986.
PMID: 36878730
Background: Corticosteroids (CSs) have previously been incorporated into graft versus host disease (GVHD) prophylaxis regimens for bone marrow (BM) and haemopoietic stem cell transplant (HSCT). Aims: To assess the impact...
4.
Lim K, Di Ciaccio P, Polizzotto M, Milliken S, Cochrane T, Goh Z, et al.
Br J Haematol
. 2023 Mar;
201(5):865-873.
PMID: 36866733
Antiretroviral therapy (ART) has improved outcomes for human immunodeficiency virus-associated non-Hodgkin lymphoma (HIV-NHL). This is an analysis of 44 patients with HIV with Burkitt lymphoma (HIV-BL) and diffuse large B-cell...
5.
Perram J, Purtill D, Bajel A, Butler J, OBrien T, Teh B, et al.
Intern Med J
. 2022 Nov;
53(1):119-125.
PMID: 36371767
Patients with post-haemopoietic stem cell transplant or chimeric antigen receptor T -cell (CAR-T) therapy face a significant risk of morbidity and mortality from coronavirus disease 2019 because of their immunosuppressed...
6.
Brennan X, Withers B, Jabbour A, Milliken S, Kotlyar E, Fay K, et al.
Intern Med J
. 2022 Oct;
52(10):1826-1830.
PMID: 36266066
Cardiac light chain (AL) amyloidosis is a condition with a very poor prognosis. We report a retrospective analysis comparing the traditional melphalan and dexamethasone protocol with cyclophosphamide, bortezomib and dexamethasone...
7.
Britton A, Vaze A, Milliken S, Fraser C
Am J Ophthalmol Case Rep
. 2022 Jul;
27:101617.
PMID: 35789798
Purpose: To report a case of recurrent and bilateral optic disc edema following intravenous immunoglobulin (IVIG) administration. Observations: A woman received IVIG on 3 separate occasions over 7 years for...
8.
Penglase R, Englert H, Tymms K, Carr A, Ma D, Milliken S, et al.
Bone Marrow Transplant
. 2022 May;
57(7):1207-1209.
PMID: 35523849
No abstract available.
9.
Withers B, McCaughan G, Hayward C, Kotlyar E, Jabbour A, Rainer S, et al.
Intern Med J
. 2020 Sep;
52(1):69-78.
PMID: 32981138
Background: Cardiac amyloidosis has a very poor prognosis, but it is the nature of the involved precursor protein that ultimately dictates treatment and survival. Aim: Definitively characterise the amyloid subtype...
10.
Cashman H, Mayson E, Kliman D, Kesby J, Bell J, Vachalec S, et al.
Intern Med J
. 2020 Jul;
51(11):1869-1875.
PMID: 32672878
Background: Rural Australian oncology patients are known to have inferior mortality rates compared to metropolitan patients, possibly related to access to appropriate healthcare services and treatments. Electronic systems improve the...